Cell death mechanisms in HIV-associated dementia: The involvement of syncytia

Cell Death and Differentiation

Volumn 12, Issue , 2005, Pages 855-858

  Nardacci, R ^a   Antinori, A ^a   Kroemer, G ^b   Piacentini, M ^a,c  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CASPASE 2; CASPASE 3; CASPASE 8; CASPASE 9; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CYTOCHROME C; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MAMMALIAN TARGET OF RAPAMYCIN; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEF PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN P53; REV PROTEIN; THROMBOCYTE ACTIVATING FACTOR; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VIRUS ENVELOPE PROTEIN; VPR PROTEIN;

APOPTOSIS; ARTICLE; CELL DEATH; CLINICAL FEATURE; DEMENTIA; DISEASE COURSE; DISEASE SEVERITY; DRUG PENETRATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; INFECTION CONTROL; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SYNCYTIUM; TREATMENT FAILURE; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS VIRULENCE;

AIDS DEMENTIA COMPLEX; ANIMALS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; APOPTOSIS; BRAIN; CYTOKINES; GIANT CELLS; HIV-1; HUMANS; MACROPHAGES; MICROGLIA; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MAMMALIA;

EID: 22744434226     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401590     Document Type: Article

References (42)

1. Navia BA et al. (1986) Ann. Neurol. 19: 517-524
2. Albright AV et al. (2003) J. Neurovirol. 9: 222-227
3. Langford TD et al. (2002) AIDS 16: 1019-1029
4. McArthur JC et al. (1993) Neurology 43: 2245-2252
5. Sacktor N et al. (2001) Neurology 56: 257-260
6. d’Arminio Monforte A et al. (2004) Ann. Neurol. 55: 320-328
7. Ellis RJ et al. (2002) Arch. Neurol. 59: 923-928
8. Antinori A et al. (2002) AIDS 16: 1867-1876
9. Letendre SL et al. (2004) Ann. Neurol. 56: 416-423
10. Sacktor N et al. (2003) Neurology 61: 567-569
11. Enting RH et al. (1998) AIDS 12: 1941-1955
12. Wendel KA et al. (2003) Clin. Infect. Dis. 37: 1107-1111
13. Gartner S (2000) Science 287: 602-604
14. Kaul M et al. (2001) Nature 410: 988-994
15. Zhang K et al. (2003) J. Virol. 77: 6899-6912
16. Bagetta G et al. (1996) NeuroReport 7: 1722-1724
17. Garden GA et al. (2002) J. Neurosci. 22: 4015-4024
18. Zheng J et al. (1999) J. Neuroimmunol. 98: 185-200
19. Catani MV et al. (2000) J. Neurochem. 74: 2373-2379
20. Klasse PJ et al. (2004) Virology 323: 1-8
21. Xu Y et al. (2004) Proc. Natl. Acad. Sci. USA 101: 7070-7075
22. Bezzi P et al. (2001) Nat. Neurosci. 4: 702-710
23. Johnston JB et al. (2000) J. Virol. 74: 7211-7220
24. Hayward P (2004) Lancet Neurol. 3: 325
25. Kaul M et al. (2004) J. Neurovirol. 1: 97-101
26. Meucci O et al. (1998) Proc. Natl. Acad. Sci. USA 95: 14500-14505
27. Petito CK et al. (1995) Am. J. Pathol. 146: 1121-1130
28. Acquas E et al. (2004) Neurotox. Res. 5: 605-615
29. Nath A et al. (2000) Ann. Neurol. 47: 186-194
30. Wesselingh SL et al. (1997) J. Neuroimmunol. 74: 1-8
31. Seol DW et al. (2001) Cancer Res. 61: 1138-1143
32. Zhang M et al. (2001) J. Biomed. Sci. 8: 290-296
33. Ryan LA et al. (2004) J. Neuroimmunol. 148: 127-139
34. Garden GA et al. (2004) FASEB J. 18: 1141-1143
35. Hengartner MO (2000) Nature 407: 770-776
36. Perfettini JL et al. J. Exp. Med. (in press)
37. Castedo M et al. (2001) J. Exp. Med. 194: 1097-1110
38. Castedo M et al. (2002) EMBO J. 21: 4070-4080
39. Perfettini JL et al. (2004) J. Exp. Med. 199: 629-640
40. Green DR et al. (2004) Science 305: 626-629
41. Nie Z et al. (2002) Cell Death Differ. 9: 1172-1184
42. Kolson DL et al. (2004) J. Neurovirol. 1: 102-107